Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01221194 · ClinicalTrials.gov registry record · NA

Therapeutic Stockings to Prevent Foot Ulcers

A NA study of Diabetes, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
381
Enrollment target
4
Study locations

NCT01221194 is a NA study of Diabetes that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 381 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (87% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01221194, a NA study of Diabetes, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
381 participants
Enrollment target
4
Study locations

Study Summary

1. To evaluate the efficacy of a therapeutic stockings (Protective Foot Care stockings, PFC) in reducing the incidence of diabetic foot pathology among high-risk patients. 2. To evaluate perceived health-related quality of life as compared to guideline directed usual care in patients who use the PFC stockings.

Conditions Studied

Interventions

  • BEHAVIORAL Standard therapy
  • DEVICE PFC Stockings

Study Locations (4)

Texas

  • Parkland Health & Hospital Systems - Dallas
  • UT Southwestern Medical Center at Dallas - Dallas
  • Scott & White - Temple

Other

  • University of Manchester - Manchester

Trial Details

FieldValue
Enrollment Target 381 participants
Start Date 2010-10
Est. Completion 2016-03
Phase NA

What the Registry Record Tells You About NCT01221194

The ClinicalTrials.gov registry entry for NCT01221194 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 381 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (87% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Standard therapy is the first listed.

NCT01221194 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Texas, Other.

Frequently Asked Questions

What is clinical trial NCT01221194 about?

NCT01221194 is a clinical study titled "Therapeutic Stockings to Prevent Foot Ulcers". 1. To evaluate the efficacy of a therapeutic stockings (Protective Foot Care stockings, PFC) in reducing the incidence of diabetic foot pathology among high-risk patients. 2. To evaluate perceived health-related quality of life as compared to guideline directed usual care in patients who use the PFC...

What is the current status of trial NCT01221194?

This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2010-10. Estimated completion is 2016-03.

What conditions does trial NCT01221194 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01221194?

The interventions under investigation include: Standard therapy (BEHAVIORAL), PFC Stockings (DEVICE).

Who is sponsoring clinical trial NCT01221194?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01221194 being conducted?

This trial has 4 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.